Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.85 | -2.65210608424 | 32.05 | 34.87 | 31 | 8182030 | 32.93935959 | CS |
| 4 | 0.51 | 1.66177908113 | 30.69 | 38.12 | 29.35 | 9265789 | 33.77693658 | CS |
| 12 | -10.81 | -25.7319685789 | 42.01 | 48.92 | 29.35 | 11443345 | 35.88163381 | CS |
| 26 | -34.49 | -52.5041863297 | 65.69 | 67.9598 | 29.35 | 9199558 | 40.05396994 | CS |
| 52 | -79.9 | -71.9171917192 | 111.1 | 170.47 | 29.35 | 6658775 | 61.65837875 | CS |
| 156 | -136 | -81.3397129187 | 167.2 | 217.25 | 29.35 | 5256662 | 103.69171736 | CS |
| 260 | 0.61 | 1.99411572409 | 30.59 | 497.17 | 28.27 | 9289794 | 147.09684744 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
